Belinostat exerts antitumor cytotoxicity through the ubiquitin-proteasome pathway in lung squamous cell carcinoma

about

Association of Smoking, Alcohol Use, and Betel Quid Chewing with Epigenetic Aberrations in Cancers.

P2860

Q33838727-E4E0C7EF-1C4B-4ABA-BB88-233A49088632

P2860

Belinostat exerts antitumor cytotoxicity through the ubiquitin-proteasome pathway in lung squamous cell carcinoma

Item

http://www.wikidata.org/entity/Q38843100

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Belinostat exerts antitumor cy ...... n lung squamous cell carcinoma

@en

type

Item

label

Belinostat exerts antitumor cy ...... n lung squamous cell carcinoma

@en

prefLabel

Belinostat exerts antitumor cy ...... n lung squamous cell carcinoma

@en

P1476

Belinostat exerts antitumor cy ...... n lung squamous cell carcinoma

@en

P2093

Boon C Goh

http://www.w3.org/2001/XMLSchema#string

Chonglei Bi

http://www.w3.org/2001/XMLSchema#string

Hung Huynh

http://www.w3.org/2001/XMLSchema#string

Soo C Lee

http://www.w3.org/2001/XMLSchema#string

Tuan Z Tan

http://www.w3.org/2001/XMLSchema#string

Wee J Chng

http://www.w3.org/2001/XMLSchema#string

Weijie R Ong

http://www.w3.org/2001/XMLSchema#string

P2860

Histone deacetylases and cancer

Carboplatin and Paclitaxel in combination with either vorinostat or placebo for first-line therapy of advanced non-small-cell lung cancer

Genetic dissection of a neurodevelopmental pathway: Son of sevenless functions downstream of the sevenless and EGF receptor tyrosine kinases

Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors

Histone acetylation and transcriptional regulatory mechanisms

A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations

Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer

Cellular processing of platinum anticancer drugs

FDA approval summary: vorinostat for treatment of advanced primary cutaneous T-cell lymphoma.

Phase II multi-institutional trial of the histone deacetylase inhibitor romidepsin as monotherapy for patients with cutaneous T-cell lymphoma

P304

965-980

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/1878-0261.12064

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Li Ren Kong

Pieter J Eichhorn

P577

2017-04-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28397399

http://www.w3.org/2001/XMLSchema#string

P921

ubiquitin-proteasome system

P932

5537703

http://www.w3.org/2001/XMLSchema#string

Belinostat exerts antitumor cytotoxicity through the ubiquitin-proteasome pathway in lung squamous cell carcinoma

about

P2860

P2860

Belinostat exerts antitumor cytotoxicity through the ubiquitin-proteasome pathway in lung squamous cell carcinoma

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932